Mesoblast Limited (ASX:MSB)
Australia · Delayed Price · Currency is AUD 2.090
+0.070 (3.47%)
At close: Mar 18, 2026
Mesoblast Market Cap
Mesoblast has a market cap or net worth of 2.7 billion as of March 18, 2026. Its market cap has decreased by -11.49% in one year.
Market Cap
2.70B
Enterprise Value
2.71B
Revenue
98.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.09
Market Cap Chart
Since December 16, 2004, Mesoblast's market cap has increased from 76.57M to 2.70B, an increase of 3,423.29%. That is a compound annual growth rate of 18.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 2.61B | -25.28% |
| Dec 31, 2025 | 3.49B | -1.80% |
| Dec 31, 2024 | 3.55B | 1,029.56% |
| Dec 29, 2023 | 314.59M | -50.91% |
| Dec 30, 2022 | 640.82M | -29.87% |
| Dec 31, 2021 | 913.81M | -30.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 3.83B |
| Neuren Pharmaceuticals | 1.49B |
| Clarity Pharmaceuticals | 1.43B |
| PYC Therapeutics | 1.39B |
| Opthea | 738.77M |
| Clinuvel Pharmaceuticals | 498.49M |
| Racura Oncology | 394.38M |
| Orthocell | 219.76M |